Celularity Inc.
CELUBiotechnology
$0.80−5.79%As of Oct 30vs prior close
- Market cap
- $26M
- P/E (TTM)
- –
- From 52W high
- −61.90%
- EPS (LTM)
- -$1.69
- Revenue (LTM)
- $18.7M
- Net margin
- -245.68%
- Dividend yield
- 0.00%
Nomior Score
31
Steady ProfileBottom 16% of the scored universe
Growth—
Quality37
Value—
Momentum38
Resilience23
Growth
+13.21%revenue a year over 5 fiscal years
YE20 $14.3MLTM $18.7M
Connections
Revenue to profitQ2 YE26
The operating loss was 78% of revenue, narrower by 199 pts on a year.
Who owns it
1fund